• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Hepatic NF-kappa B essential modulator deficiency prevents obesity-induced insulin resistance but synergizes with high-fat feeding in tumorigenesis.肝脏核因子κB必需调节因子缺乏可预防肥胖诱导的胰岛素抵抗,但在肿瘤发生中与高脂喂养协同作用。
Proc Natl Acad Sci U S A. 2008 Jan 29;105(4):1297-302. doi: 10.1073/pnas.0707849104. Epub 2008 Jan 23.
2
Interferon regulatory factor 3 constrains IKKβ/NF-κB signaling to alleviate hepatic steatosis and insulin resistance.干扰素调节因子 3 限制 IKKβ/NF-κB 信号转导以减轻肝脂肪变性和胰岛素抵抗。
Hepatology. 2014 Mar;59(3):870-85. doi: 10.1002/hep.26751. Epub 2014 Jan 30.
3
N-3 long-chain PUFA supplementation prevents high fat diet induced mouse liver steatosis and inflammation in relation to PPAR-α upregulation and NF-κB DNA binding abrogation.补充N-3长链多不饱和脂肪酸可预防高脂饮食诱导的小鼠肝脏脂肪变性和炎症,这与过氧化物酶体增殖物激活受体-α(PPAR-α)上调及核因子-κB(NF-κB)DNA结合消除有关。
Mol Nutr Food Res. 2014 Jun;58(6):1333-41. doi: 10.1002/mnfr.201300458. Epub 2014 Jan 16.
4
Mindin/Spondin 2 inhibits hepatic steatosis, insulin resistance, and obesity via interaction with peroxisome proliferator-activated receptor α in mice.Mindin/Spondin 2 通过与过氧化物酶体增殖物激活受体 α 的相互作用抑制小鼠肝脂肪变性、胰岛素抵抗和肥胖。
J Hepatol. 2014 May;60(5):1046-54. doi: 10.1016/j.jhep.2014.01.011. Epub 2014 Jan 18.
5
Dietary capsaicin reduces obesity-induced insulin resistance and hepatic steatosis in obese mice fed a high-fat diet.膳食辣椒素可降低高脂肪饮食诱导肥胖小鼠的肥胖诱导性胰岛素抵抗和肝脂肪变性。
Obesity (Silver Spring). 2010 Apr;18(4):780-7. doi: 10.1038/oby.2009.301. Epub 2009 Oct 1.
6
Hepatocyte-specific Ptpn6 deletion promotes hepatic lipid accretion, but reduces NAFLD in diet-induced obesity: potential role of PPARγ.肝细胞特异性 Ptpn6 缺失促进肝内脂质蓄积,但可减少饮食诱导肥胖的非酒精性脂肪性肝病:PPARγ 的潜在作用。
Hepatology. 2014 May;59(5):1803-15. doi: 10.1002/hep.26957. Epub 2014 Apr 1.
7
Liver-specific Prkn knockout mice are more susceptible to diet-induced hepatic steatosis and insulin resistance.肝特异性 Prkn 敲除小鼠更容易发生饮食诱导的肝脂肪变性和胰岛素抵抗。
Mol Metab. 2020 Nov;41:101051. doi: 10.1016/j.molmet.2020.101051. Epub 2020 Jul 10.
8
Inactivation of NF-κB p65 (RelA) in Liver Improves Insulin Sensitivity and Inhibits cAMP/PKA Pathway.肝脏中NF-κB p65(RelA)的失活可改善胰岛素敏感性并抑制cAMP/PKA途径。
Diabetes. 2015 Oct;64(10):3355-62. doi: 10.2337/db15-0242. Epub 2015 Jun 2.
9
Myeloid cell TRAF3 promotes metabolic inflammation, insulin resistance, and hepatic steatosis in obesity.髓系细胞TRAF3在肥胖中促进代谢性炎症、胰岛素抵抗和肝脂肪变性。
Am J Physiol Endocrinol Metab. 2015 Mar 15;308(6):E460-9. doi: 10.1152/ajpendo.00470.2014. Epub 2015 Jan 27.
10
Local and systemic insulin resistance resulting from hepatic activation of IKK-beta and NF-kappaB.由IKK-β和NF-κB的肝脏激活导致的局部和全身胰岛素抵抗。
Nat Med. 2005 Feb;11(2):183-90. doi: 10.1038/nm1166. Epub 2005 Jan 30.

引用本文的文献

1
Epithelial barrier hypothesis in the context of nutrition, microbial dysbiosis, and immune dysregulation in metabolic dysfunction-associated steatotic liver.代谢功能障碍相关脂肪性肝病中营养、微生物群失调和免疫失调背景下的上皮屏障假说
Front Immunol. 2025 May 14;16:1575770. doi: 10.3389/fimmu.2025.1575770. eCollection 2025.
2
Novel perspectives on the link between obesity and cancer risk: from mechanisms to clinical implications.肥胖与癌症风险关联的新视角:从机制到临床意义
Front Med. 2024 Dec;18(6):945-968. doi: 10.1007/s11684-024-1094-2. Epub 2024 Nov 14.
3
Alcohol, White Adipose Tissue, and Brown Adipose Tissue: Mechanistic Links to Lipogenesis and Lipolysis.酒精、白色脂肪组织和棕色脂肪组织:与脂肪生成和脂肪分解的机制联系。
Nutrients. 2023 Jun 29;15(13):2953. doi: 10.3390/nu15132953.
4
Hepatic Insulin Resistance Model in the Male Wistar Rat Using Exogenous Insulin Glargine Administration.使用外源性甘精胰岛素给药建立雄性Wistar大鼠肝胰岛素抵抗模型。
Metabolites. 2023 Apr 18;13(4):572. doi: 10.3390/metabo13040572.
5
Insights on the NF-κB system in polycystic ovary syndrome, attractive therapeutic targets.多囊卵巢综合征中 NF-κB 系统的研究进展:有吸引力的治疗靶点。
Mol Cell Biochem. 2024 Mar;479(3):467-486. doi: 10.1007/s11010-023-04736-w. Epub 2023 Apr 25.
6
Heterogeneous effects of individual high-fat diet compositions on phenotype, metabolic outcome, and hepatic proteome signature in BL/6 male mice.不同高脂饮食成分对BL/6雄性小鼠的表型、代谢结果和肝脏蛋白质组特征的异质性影响。
Nutr Metab (Lond). 2023 Feb 8;20(1):8. doi: 10.1186/s12986-023-00729-0.
7
Cell death and inflammation during obesity: "Know my methods, WAT(son)".肥胖症发生过程中的细胞死亡与炎症:“了解我的方法,脂肪组织(儿子)”。
Cell Death Differ. 2023 Feb;30(2):279-292. doi: 10.1038/s41418-022-01062-4. Epub 2022 Sep 29.
8
extract improves metabolic derangements in high fructose diet-fed rats.提取物可改善高果糖饮食喂养大鼠的代谢紊乱。
Anim Cells Syst (Seoul). 2021 Nov 22;25(6):396-404. doi: 10.1080/19768354.2021.2004221. eCollection 2021.
9
Insulin Resistance: From Mechanisms to Therapeutic Strategies.胰岛素抵抗:从机制到治疗策略。
Diabetes Metab J. 2022 Jan;46(1):15-37. doi: 10.4093/dmj.2021.0280. Epub 2021 Dec 30.
10
Roles of IκB kinases and TANK-binding kinase 1 in hepatic lipid metabolism and nonalcoholic fatty liver disease.IKK 激酶和 TANK 结合激酶 1 在肝脏脂质代谢和非酒精性脂肪性肝病中的作用。
Exp Mol Med. 2021 Nov;53(11):1697-1705. doi: 10.1038/s12276-021-00712-w. Epub 2021 Nov 30.

本文引用的文献

1
Deletion of NEMO/IKKgamma in liver parenchymal cells causes steatohepatitis and hepatocellular carcinoma.肝实质细胞中NEMO/IKKγ的缺失会导致脂肪性肝炎和肝细胞癌。
Cancer Cell. 2007 Feb;11(2):119-32. doi: 10.1016/j.ccr.2006.12.016.
2
Functional in vivo interactions between JNK1 and JNK2 isoforms in obesity and insulin resistance.肥胖和胰岛素抵抗中JNK1与JNK2亚型之间的体内功能相互作用。
Proc Natl Acad Sci U S A. 2006 Jul 11;103(28):10741-6. doi: 10.1073/pnas.0603509103. Epub 2006 Jul 3.
3
Role of hepatic STAT3 in brain-insulin action on hepatic glucose production.肝脏中信号转导与转录激活因子3(STAT3)在大脑胰岛素对肝脏葡萄糖生成作用中的角色。
Cell Metab. 2006 Apr;3(4):267-75. doi: 10.1016/j.cmet.2006.02.009.
4
Peroxisome proliferator-activated receptor alpha mediates the effects of high-fat diet on hepatic gene expression.过氧化物酶体增殖物激活受体α介导高脂饮食对肝脏基因表达的影响。
Endocrinology. 2006 Mar;147(3):1508-16. doi: 10.1210/en.2005-1132. Epub 2005 Dec 15.
5
Tumor necrosis factor-alpha induces skeletal muscle insulin resistance in healthy human subjects via inhibition of Akt substrate 160 phosphorylation.肿瘤坏死因子-α通过抑制Akt底物160磷酸化诱导健康人类受试者骨骼肌胰岛素抵抗。
Diabetes. 2005 Oct;54(10):2939-45. doi: 10.2337/diabetes.54.10.2939.
6
Increased expression of PPARgamma in high fat diet-induced liver steatosis in mice.PPARγ在高脂饮食诱导的小鼠肝脏脂肪变性中的表达增加。
Biochem Biophys Res Commun. 2005 Oct 14;336(1):215-22. doi: 10.1016/j.bbrc.2005.08.070.
7
Non-parenchymal liver cells support the growth advantage in the first stages of hepatocarcinogenesis.非实质肝细胞在肝癌发生的最初阶段支持生长优势。
Carcinogenesis. 2006 Jan;27(1):152-61. doi: 10.1093/carcin/bgi202. Epub 2005 Aug 4.
8
Obesity and cancer: the risks, science, and potential management strategies.肥胖与癌症:风险、科学及潜在管理策略
Oncology (Williston Park). 2005 Jun;19(7):871-81; discussion 881-2, 885-6.
9
IKKbeta couples hepatocyte death to cytokine-driven compensatory proliferation that promotes chemical hepatocarcinogenesis.IKKβ 将肝细胞死亡与细胞因子驱动的代偿性增殖联系起来,这种增殖促进化学性肝癌发生。
Cell. 2005 Jul 1;121(7):977-90. doi: 10.1016/j.cell.2005.04.014.
10
Deletion of IKK2 in hepatocytes does not sensitize these cells to TNF-induced apoptosis but protects from ischemia/reperfusion injury.肝细胞中IKK2的缺失不会使这些细胞对肿瘤坏死因子诱导的凋亡敏感,但能保护其免受缺血/再灌注损伤。
J Clin Invest. 2005 Apr;115(4):849-59. doi: 10.1172/JCI23493. Epub 2005 Mar 17.

肝脏核因子κB必需调节因子缺乏可预防肥胖诱导的胰岛素抵抗,但在肿瘤发生中与高脂喂养协同作用。

Hepatic NF-kappa B essential modulator deficiency prevents obesity-induced insulin resistance but synergizes with high-fat feeding in tumorigenesis.

作者信息

Wunderlich F Thomas, Luedde Tom, Singer Stephan, Schmidt-Supprian Marc, Baumgartl Julia, Schirmacher Peter, Pasparakis Manolis, Brüning Jens C

机构信息

Department of Mouse Genetics and Metabolism, Institute for Genetics, University of Cologne and Center of Molecular Medicine Cologne, D-50674 Cologne, Germany.

出版信息

Proc Natl Acad Sci U S A. 2008 Jan 29;105(4):1297-302. doi: 10.1073/pnas.0707849104. Epub 2008 Jan 23.

DOI:10.1073/pnas.0707849104
PMID:18216263
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2234132/
Abstract

Development of obesity-associated insulin resistance and diabetes mellitus type 2 has been linked to activation of proinflammatory pathways in the liver, leading to impaired insulin signal transduction. To further define the role of hepatic NF-kappaB activation in this process, we have analyzed glucose metabolism in mice with liver-specific inactivation of the NF-kappaB essential modulator gene (NEMO(L-KO) mice) exposed to a high-fat diet (HFD). These animals are protected from the development of obesity-associated insulin resistance, highlighting the importance of hepatic NF-kappaB activation in this context. However, hepatic NEMO deficiency synergizes with HFD in the development of liver steatosis as a consequence of decreased peroxisome proliferator-activated receptor (PPAR-alpha) and increased PPAR-gamma expression. Steatosis interacts with increased inflammation, causing elevated apoptosis in the livers of these mice under HFD. These changes result in liver tumorigenesis of NEMO(L-KO) mice under normal diet, a process that is largely aggravated when these mice are exposed to HFD. These data directly demonstrate the interaction of hepatic inflammation, dietary composition, and metabolism in the development of liver tumorigenesis.

摘要

肥胖相关的胰岛素抵抗和2型糖尿病的发生与肝脏中促炎途径的激活有关,导致胰岛素信号转导受损。为了进一步明确肝脏中核因子κB(NF-κB)激活在此过程中的作用,我们分析了在高脂饮食(HFD)条件下肝脏特异性失活NF-κB必需调节基因的小鼠(NEMO(L-KO)小鼠)的葡萄糖代谢情况。这些动物可免受肥胖相关胰岛素抵抗的发生,这凸显了在此背景下肝脏NF-κB激活的重要性。然而,肝脏NEMO缺乏与HFD协同作用,导致肝脏脂肪变性,其原因是过氧化物酶体增殖物激活受体(PPAR-α)表达降低和PPAR-γ表达增加。脂肪变性与炎症增加相互作用,导致这些小鼠在HFD条件下肝脏细胞凋亡增加。这些变化导致NEMO(L-KO)小鼠在正常饮食条件下发生肝脏肿瘤,当这些小鼠暴露于HFD时,这一过程会大大加剧。这些数据直接证明了肝脏炎症、饮食组成和代谢在肝脏肿瘤发生发展过程中的相互作用。